This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genentech, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Araz Jakalian: Innovator in Cancer Treatment
Introduction
Araz Jakalian is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Jakalian holds a patent for "Lactams as CBL-B inhibitors selective over C-CBL." This compound, represented by the formula (I), is designed for treating cancers that are susceptible to the inhibition of Cbl-B. His work in this area highlights the potential for targeted therapies in oncology.
Career Highlights
Araz Jakalian is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to further his research and contribute to advancements in cancer treatment.
Collaborations
Throughout his career, Jakalian has collaborated with esteemed colleagues, including Malcolm Huestis and Michael John Lambrecht. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.
Conclusion
Araz Jakalian's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His contributions through patents and collaborations continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile